Newly published preclinical research signals a substantial conceptual shift with a potential role of photon-counting CT in targeting specific biological processes.
|Articles|July 8, 2011
Medicare Will Pay For MRIs When Patient Has Pacemaker
Author(s)Diagnostic Imaging Staff
Radiologists can now charge Medicare for MRIs when the patient has a pacemarker approved for MRI exams.
Advertisement
The Centers for Medicare & Medicaid Services (CMS) has expanded coverage to include MRI for beneficiaries with implanted pacemakers when used according to FDA-approved labeling in an MRI environment.
A final National Coverage Determination posted today provides access to the MRI environment for patients with FDA-approved pacemakers.
On February 8,
Advertisement
Related to this article
A Kaiser score > 5 with breast MRI demonstrated a 97 percent sensitivity and 87.9 percent specificity for predicting malignancy in patients with BI-RADS 0 or 4 presentations on mammography and breast ultrasound, according to a new study.
In a recent interview, Francesco Giganti, MD, PhD, discussed findings from a recent multicenter study demonstrating the ability of an AI software to provide significant clarity to initial PI-RADS 3 assessments on MRI and facilitate a nearly 19 percent reduction in unnecessary prostate biopsies.
The NEXT-Cue AI software, which incorporates analysis of brain MRI scans, reportedly facilitates prognostic assessments of potential progression from mild cognitive impairment (MCI) to Alzheimer’s disease within five years.
Catch up on the top radiology content of the past week.
Assessing breast MRI scans, pathology and clinical data, the AI-powered TumorSight Risk software reportedly provides five- and 10-year risk for breast cancer recurrence for women with HR+, HER2-negative stage I-IIIA breast cancer.
Catch up on the latest imaging research presented at the recent American Society for Radiation Oncology (ASTRO) Annual Meeting.
Tightness of the high-convexity sulci (THC) on brain MRI was associated with nearly threefold higher odds of cognitive decline over five to seven years of follow-up, according to a new prospective study involving over 2,100 community-dwelling senior citizens.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Could Photon-Counting CT Have an Impact as a Platform for Molecular Imaging?
2
What’s Next for AI in Radiology?: Facilitating Data Orchestration Over Fragmentation
3
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
4
FDA Clears Machine Learning Module for Emerging Musculoskeletal Ultrasound Platform
5